VVD-214 (VVD-133214, RO7589831)

VVD-214 (VVD-133214, RO7589831) is an inhibitor linked to DNA Damage Response and Apoptosis and related pathway-oriented research. In practice, this places the compound in experiments that measure checkpoint activation, DNA repair, and genome-stability control and caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and dna damage / repair models.

The pathway annotation connects VVD-214 (VVD-133214, RO7589831) to DNA Damage Response and Apoptosis, supporting experiments that monitor checkpoint activation, DNA repair, and genome-stability control and caspase-associated cell-death signaling and survival decisions across biochemical, cellular, or phenotypic assay formats. This context is compatible with DNA-repair, checkpoint, and genotoxic-stress assays and apoptosis, viability, and caspase-readout assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis, cancer, and dna damage / repair models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Pathway perturbation studies connected to DNA Damage Response and Apoptosis
• Concentration-response inhibition and target-dependence studies
• Phenotypic profiling in apoptosis, cancer, and dna damage / repair models
• Combination studies with orthogonal perturbagens

Overall, VVD-214 (VVD-133214, RO7589831) is well suited to pathway-oriented studies that need a defined compound input for DNA Damage Response and Apoptosis readouts in apoptosis, cancer, and dna damage / repair models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.